China SXT Pharmaceuticals, Inc. (SXTC) शेयर — क्या यह अच्छा व्यवसाय है?

China SXT Pharmaceuticals, Inc. (SXTC) शेयर — क्या यह अच्छा व्यवसाय है? — InspectStocks

Keep exploring

The themes China SXT Pharmaceuticals is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Drug Manufacturers Specialty and Generic

Graded A or B and worth $2B or more: A first, then the largest.

All 78 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

कमाई कैसे होती है

Regular traditional Chinese medicine pieces95%
Advanced traditional Chinese medicine pieces4%

आमदनी के हिस्से year ended March 31, 2026 के अनुमान हैं, किसी दाख़िल रिपोर्ट के आँकड़े नहीं।

मुकाबला किनसे है

600518Kangmei Pharmaceutical Co., Ltd.
300147Xiangxue Pharmaceutical Co., Ltd.

क्या बेचती है6

Regular traditional Chinese medicine pieces
Medicinal plants processed into forms such as cut pieces or powders, generally prepared by boiling or decoction before use.
Directly-Oral advanced TCMP
Processed herbal medicines made to be taken by mouth without first being boiled as a decoction.
After-Soaking-Oral advanced TCMP
Small sealed bags of herbal material steeped in hot water to make an infusion.

3 और दिखाएँ

SanQiFen
A directly swallowed powder made from the roots and rhizomes of notoginseng.
CuYanHuSuo
A directly swallowed powder made from the tubers of Corydalis yanhusuo.
LuXueJing
A directly swallowed product made from dried deer blood.

कौन खरीदता है3

Hospitals, especially traditional Chinese medicine hospitals, buy products for patient care, mainly in Jiangsu province.
Pharmaceutical wholesalers buy products and distribute them to hospitals and other healthcare distributors.
As of March 31, 2026, end customers included 46 pharmaceutical companies, 11 chain pharmacies and 12 hospitals (March 31, 2026, high).

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1Relies on medicinal-plant raw materials supplied by vendors in China.
2Relies on a limited number of customers; hospitals and pharmaceutical distributors account for important sales channels.
3Its business in China depends on contractual arrangements with Taizhou Suxuantang, a variable interest entity, rather than direct ownership of that operating company.

क्या ग़लत हो सकता है

1Losing or reducing sales to a small number of major customers could harm revenue.
2Disruptions in the supply of medicinal plants or other raw materials could interrupt production and deliveries.
3The company may be unable to enforce its contractual arrangements with Taizhou Suxuantang, or changes in Chinese rules may affect those arrangements or its ability to operate.

पूरे वित्तीय विवरण →

China SXT Pharmaceuticals, Inc. के बारे में

China SXT makes traditional Chinese medicine pieces (TCMP) from medicinal plants, including herbs prepared as powders and other forms. In the fiscal year ended March 31, 2026, regular TCMP made up 95.02% of revenue (FY2026, high), while advanced TCMP made up 4.35% (FY2026, high); some advanced products can be swallowed directly or steeped in hot water. Total revenue was $1,138,052 (year ended March 31, 2026, high).

मुख्यालय: Taizhou, Jiangsu, China
स्थापना: 2017
कर्मचारी: 56 full-time employees (March 31, 2026, high)
सूचीबद्ध: Nasdaq Capital Market
वित्त वर्ष का अंत: March 31

China SXT Pharmaceuticals, Inc. की अपनी रिपोर्टों से बना, जो अमेरिकी प्रतिभूति और विनिमय आयोग (SEC) में दाखिल की गईं। आँकड़े जैसे बताए गए, और प्रति-शेयर इतिहास आज के शेयर आधार पर पुनर्गणित। यह एक व्यवसाय का वर्णन है — यह निवेश सलाह नहीं है और न ही कुछ खरीदने या बेचने की सिफ़ारिश।

Keep exploring

The themes China SXT Pharmaceuticals is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.